The durability of ventricular assist device (VAD) therapy improved steadily over the past
years. However, driveline infections remain a challenge. To test whether an improved …

Background Driveline infection (DLI) is one of the leading causes for unplanned re-
admissions of patients undergoing therapy with left ventricular assist devices (LVAD). In …

Different left ventricular assist devices (LVADs) are provided of different driveline exit sites:
HeartWare HVAD presents abdominal power-cable-supply, while the Jarvik 2000 LVAD is …

Although the survival rate for left ventricular assist device (LVAD) therapy has improved,
device-related complications are an unpredictable threat to the patient's quality of life. We …

A driveline exit site infection is a serious and common complication in long-term left
ventricular assist device (LVAD) support. To reduce the incidence and severity of late …

Abstract BACKGROUND AND AIM OF THE STUDY Driveline infections in patients with
implantable left ventricular assist devices (VAD) carry increasing risk for pump infection …

Infection is a major source of morbidity and mortality after ventricular assist device (VAD)
implantation. The percutaneous driveline is the most common site of infection in these …

Left ventricular assist devices (LVADs) are increasingly utilized in the management of
advanced heart failure. A transcutaneous driveline is necessary to power the LVAD, and …

Mechanical circulatory support is increasingly being used as bridge-to-transplant and
destination therapy in patients with advanced heart failure. Technologic improvements have …

BACKGROUND: A successful left ventricular assist device (LVAD) long-term support in an
outpatient setting demands that device-related complications are reduced to a minimum. We …